Patents Assigned to Terapia Celular, LN, Inc.
  • Publication number: 20130224774
    Abstract: Ultrafine particles are provided having a core region that has a signal amplifying molecule and a shell region that surrounds the core region. The shell region has at least one antibody affixed to its surface that is specific for at least one antigen. Alternatively, the ultrafine particles may entrap the signal amplifying molecule within its matrix and may also have antibodies affixed to its surface for molecular recognition. Ultrafine particles are also provided having a matrix component that includes a signal amplifying molecule and at least one antibody specific for the antigen or biomaterial. The ultrafine particles of the present disclosure may be used in assays for the detection, including quantification, of one or more antigens present in a biological sample.
    Type: Application
    Filed: April 1, 2013
    Publication date: August 29, 2013
    Applicant: Terapia Celular, LN, Inc.
    Inventor: Terapia Celular, LN, Inc.
  • Patent number: 8297959
    Abstract: Capsules and particles with at least one encapsulated and/or entrapped agent, such as therapeutic agent, imaging agents, and other constituents may be produced by electrohydrodynamic processes. More particularly, the agent encapsulated in a vehicle, capsule, particle, vector, or carrier may maximize treatment and/or imaging of malignant cancers while minimizing the adverse effects of treatment and/or imaging.
    Type: Grant
    Filed: May 2, 2007
    Date of Patent: October 30, 2012
    Assignee: Terapia Celular, LN, Inc.
    Inventors: Gustavo Larsen, Ruben Spretz, Raffet Velarde-Ortiz, David Vu, Luis Nunez